2-167136051-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_152381.6(XIRP2):c.551G>A(p.Arg184His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000206 in 1,600,228 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_152381.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
XIRP2 | NM_152381.6 | c.551G>A | p.Arg184His | missense_variant | 3/11 | ENST00000409195.6 | |
XIRP2-AS1 | NR_046665.1 | n.154+4751C>T | intron_variant, non_coding_transcript_variant | ||||
XIRP2 | NM_001199143.2 | c.551G>A | p.Arg184His | missense_variant | 3/11 | ||
XIRP2 | NM_001079810.4 | c.551G>A | p.Arg184His | missense_variant | 3/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
XIRP2 | ENST00000409195.6 | c.551G>A | p.Arg184His | missense_variant | 3/11 | 5 | NM_152381.6 | ||
XIRP2-AS1 | ENST00000525330.1 | n.154+4751C>T | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152082Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000336 AC: 8AN: 238172Hom.: 0 AF XY: 0.0000385 AC XY: 5AN XY: 129730
GnomAD4 exome AF: 0.0000207 AC: 30AN: 1448146Hom.: 0 Cov.: 30 AF XY: 0.0000208 AC XY: 15AN XY: 720350
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152082Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74276
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 11, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at